Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-12-23
pubmed:abstractText
Extended daily dialysis (EDD) combines the advantage of both intermittent hemodialysis and continuous renal replacement therapy: excellent detoxification accompanied by cardiovascular tolerability. The aim of this study was to evaluate pharmacokinetics of meropenem and vancomycin in critically ill patients with renal failure undergoing EDD.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0090-3493
pubmed:author
pubmed:issnType
Print
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
51-6
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed-meshheading:16374156-Acute Kidney Injury, pubmed-meshheading:16374156-Adult, pubmed-meshheading:16374156-Aged, pubmed-meshheading:16374156-Critical Care, pubmed-meshheading:16374156-Dose-Response Relationship, Drug, pubmed-meshheading:16374156-Drug Administration Schedule, pubmed-meshheading:16374156-Drug Monitoring, pubmed-meshheading:16374156-Female, pubmed-meshheading:16374156-Follow-Up Studies, pubmed-meshheading:16374156-Humans, pubmed-meshheading:16374156-Intensive Care Units, pubmed-meshheading:16374156-Male, pubmed-meshheading:16374156-Middle Aged, pubmed-meshheading:16374156-Prospective Studies, pubmed-meshheading:16374156-Renal Dialysis, pubmed-meshheading:16374156-Risk Assessment, pubmed-meshheading:16374156-Thienamycins, pubmed-meshheading:16374156-Treatment Outcome, pubmed-meshheading:16374156-Vancomycin
pubmed:year
2006
pubmed:articleTitle
Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis.
pubmed:affiliation
Department of Medicine, Division of Nephrology, Medical School Hannover, Hannover, Germany.
pubmed:publicationType
Journal Article, Clinical Trial, Comparative Study